clinical

Anteris Announces Results for the Second Quarter of 2025

MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR,…

3 days ago

XORTX Completes USD $114,500 Private Placement

August 08, 2025 19:54 ET  | Source: XORTX Therapeutics Inc. NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICESOR FOR…

5 days ago

Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer

TAIPEI, Aug. 4, 2025 /PRNewswire/ -- Anbogen Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved…

5 days ago

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

BOSTON and ROLLE, Switzerland, Aug. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a…

6 days ago

Guidelines for Osstem Implants, Implant Fracture and Peripheral Diseases are Presented

Listed in the prestigious international academic journal, MDPI 'Prosthesis' SEOUL, South Korea, Aug. 6, 2025 /PRNewswire/ -- Osstem Implants, the…

1 week ago

Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

Mechelen, Belgium; August 6, 2025, 7:30 CET; regulated information – inside information – Galapagos NV (Euronext & NASDAQ: GLPG) today…

1 week ago

Aicuris Presents Pharmacokinetic Data from the First-in-Human Clinical Trial of AIC468, a Novel Antisense Oligonucleotide Targeting BK Virus, at World Transplant Congress

Initial results from the First in Human (FIH) Phase 1 trial evaluating AIC468, a 2nd generation antisense oligonucleotide (ASO), in…

1 week ago

SmartVascular Dx Test Elevates Vascular Risk Detection in the Northeast & Partnership with MOMS

IRVINE, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC., (“MSL” or “the Company”), a leading developer of precision diagnostic…

2 weeks ago

Medit to Reveal New Medit i900 Mobility, Powered by True Mobility

SEOUL, South Korea, Aug. 1, 2025 /PRNewswire/ -- Medit (www.medit.com), a global leader in digital dentistry, today introduces the Medit i900 Mobility,…

2 weeks ago

Emerald Clinical Trials Confirms CEO Transition and Continuity Plan

SINGAPORE, July 30, 2025 /PRNewswire/ -- Emerald Clinical Trials, a leading global clinical research organization, today announced a leadership transition.…

2 weeks ago